
China Needs Stronger Ethical Safeguards in Biomedicine
As the country seeks to become a research powerhouse, it must rectify worrisome practices
As the country seeks to become a research powerhouse, it must rectify worrisome practices
Research into molecular biomarkers is quickly moving from the lab to the clinic. It promises to transform how doctors diagnose and treat disease.
Gene transcription is one of life’s most fundamental processes. For the first time, researchers have viewed it in real time in a living cell.
To avoid stagnated growth and labor shortfalls, the U.S. must rethink its approach now
What can our genes tell us about which diet will work best for us?
You can find good information, but there's a lot more bad
An elaborate setup allowed researchers to study how people stumble and recover
Rapid molecular tests for influenza are as quick as older on-the-spot tests and much more accurate. But that might not be enough to drive widespread adoption
Scientists can track influenza in real time by monitoring social media, leading to more accurate predictions
Companies such as 23andMe and Ancestry.com have made it impossible for sperm banks to keep donors’ identities secret
The research could eventually lead to new sources of organs for transplant, but ethical and technical hurdles need to be overcome
Discount coupons let patients pin down costs before treatment, but raise worries about unnecessary tests and radiation
The CRISPR technique can trigger the new material to release drugs or pick up biological signals
At-home video sessions and apps could reduce costs and expand treatment in rural areas
Patients can pay hundreds to thousands of dollars to screen for genetic health risks
The soft wearable could prove useful for military applications, emergencies and medical rehabilitation
In the first of two meetings, an international commission discussed the criteria required before such experiments should be conducted—if ever
The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease
On Tuesday, an international commission will meet to develop less ambiguous guidelines for embryo editing
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account